Free accessResearch articleFirst published online 2014-7
Seed Dormancy Breaking Diterpenoids from the Liverwort Plagiochila sciophila and their Differentiation Inducing Activity in Human Promyelocytic Leukemia HL-60 Cells
To obtain the structural diversity of bioactive compounds similar to cotylenins and fusicoccins that modulate 14-3-3 protein-protein interactions in eukaryotes, screening tests were carried out using the lettuce seed dormancy breaking-assay. An acetone extract of the liverwort Plagiochila sciophila exhibited significant activity against the seeds in the presence of the plant hormone abscisic acid. Activity-guided fractionation of the extract afforded the isolation of seven novel fusicoccane-type diterpenoids, named fusicosciophins A-E (1–5), 8-deacetyl (6) and 9-deacetyl fusicosciophin E (7). Their structures were determined by spectroscopic methods and X-ray crystallographic analyses. All the pure isolated compounds (1–7) exhibited moderate lettuce seed dormancy breaking activity. In addition, the differentiation-inducing activity and cytotoxicity of these isolates, together with fusicoccin A (FC-A) and all-trans retinoic acid (ATRA), were evaluated in human promyelocytic leukemia HL-60 cells and human mouth epidermal carcinoma KB cells, respectively. Fusicosciophins (2 and 4) and FC-A exhibited moderate differentiation-inducing activity (EC50 31.2~59.1μM) compared with ATRA (EC50 0.3μM), while 2, 4 and ATRA exhibited higher selectivity indices (IC50/EC50 >3.38~667) than FC-A (IC50/EC50 1.05). This is the first report on the isolation of fusicoccane-type diterpenoids from liverworts having seed dormancy breaking activity and differentiation-inducing activity in mammal cells.
(a) BallioA., BrufaniM., CasinoviC.G., CerriniS., FedeliW., PellicciariR., SanturbanoB., VaciagoA. (1968) The structure of fusicoccin A. Experientia, 24, 631–635; (b) Barrow KD, Barton DHR, Chain EB, Ohnsorge UFW, Thomas R. (1968) The constitution of fusicoccin. Chemical Communications, 1198–1200; (c) Ballio A, Casinovi CG, D'Alessio V, Grandolini G, Randazzo G, Rossi C. (1974) 19-Deoxydideacetyl-fusicoccin, a minor metabolite of Fusicoccum amygdali Del. Experientia, 30, 1108–1109; (d) Barrow KD, Barton DHR, Chain E, Bageenda-Kasujja D, Mellows G. (1975) Fusicoccin. Part IV. The structure of fusicoccin J. Journal of the Chemical Society, Perkin Transactions 1, 877–883.
2.
(a) SassaT. (1971) Cotylenins, Leaf growth substances produced by a fungus. Part I. Isolation and characterization of cotylenins A and B. Agricultural and Biological Chemistry, 35, 1415–1418; (b) Sassa T, Takahama A, Shindo T. (1975) The stereostructure of cotylenol, the aglycone of cotylenins, leaf growth substances. Agricultural and Biological Chemistry, 39, 1729–1734; (c) Sassa T, Ooi T, Nukina M, Kato N. (1998) Structural confirmation of cotylenin A, a novel fusicoccane-diterpene glycoside with potent plant growth-regulating activity from Cladosporium fungus sp. 501–7W. Bioscience, Biotechnology and Biochemistry, 62, 1815–1818.
3.
(a) MackinnonS.L., KeiferP., AyerW.A. (1999) Components from the phytotoxic extract of Alternaria brassicicola, a black spot pathogen of canola. Phytochemistry, 51, 215–221; (b) Pedras MSC, Chumala PB, Jin W, Islam MS, Hauck DW. (2009) The phytopathogenic fungus Alternaria brassicicola: Phytotoxin production and phytoalexin elicitation Phytochemistry, 70, 394–402. (c) Kenmoku H, Takeue S, Oogushi M, Yagi Y, Sassa T, Toyota M, Asakawa Y. (2014) Seed dormancy breaking diterpenoids, including novel brassicicenes J and K, from fungus Alternaria brassicicola, and their necrotic/apoptotic activities in HL-60 cells. Natural Product Communications, 9, 351–354.
4.
(a) HashimotoT., ToriM., TairaZ., AsakawaY. (1985) New highly oxidized fusicoccane diterpenoids from the liverwort Plagiochila acanthophylla subsp. japonica. Tetrahedron Letters, 26, 6473–6476; (b) Asakawa Y, Ludwiczuk A, Nagashima F. (2003) Chemical constituents of bryophytes: Bio- and chemical diversity, biological activity, and chemosystematics. In Progress in the Chemistry of Organic Natural Products.KinghornA.D., FalkH.KobayashiJ. (Eds). Vol. 95, Springer, Vienna, 1–796.
5.
(a) AdesomojuA.A., OkogunJ.I., CavaM.P., CarrollP.J. (1983) Roseadione, a diterpene ketone from Hypoestes rosea. Phytochemistry, 22, 2535–2536; (b) Muhammad I, Mossa JS, AlYahya MA, ElFeraly FS, McPhail AT. (1997) Hypoestenone: a fusicoccane diterpene ketone from Hypoestes forskalei. Phytochemistry, 44, 125–129; (c) Muhammad I, Mossa JS, Ramadan AF, El-Feraly FS, Hufford CD. (1998) Additional diterpene ketones from Hypoestes forskalei. Phytochemistry, 47, 1331–1336; (d) Rasoamiaranjanahary L, Marston A, Guilet D, Schenk K, Randimbivololona F, Hostettmann K. (2003) Antifungal diterpenes from Hypoestes serpens (Acanthaceae). Phytochemistry, 62, 333–337.
6.
(a) SassaT., TajimaN., SatoM., TakahashiA., KatoN. (2002) Fusicoccins P and Q, and 3-epifusicoccins H and Q, new polar fusicoccins from isolate Niigata 2-A of a peach Fusicoccum canker fungus. Bioscience, Biotechnology and Biochemistry, 66, 2356–2361; (b) Tajima N, Nukina M, Kato N, Sassa T. (2004) Novel fusicoccins R and S, and the fusicoccin S aglycon (phomopsiol) from Phomopsis amygdali Niigata 2-A, and their seed germination-stimulating activity in the presence of abscisic acid. Bioscience, Biotechnology and Biochemistry, 68, 1125–1130.
7.
(a) WürteleM., Jelich-OttmannC., WittinghoferA., OeckingC. (2003) Structural view of a fungal toxin acting on a 14–3–3 regulatory complex. The EMBO Journal, 22, 987–994; (b) Ottmann C, Marco S, Jaspert N, Marcon C, Schauer N, Weyand M, Van der meeren C, Duby G, Boutry M, Wittinghofer A, Rigaud JL, Oecking C. (2007) Structure of a 14–3–3 coordinated hexamer of the plant plasma membrane H+-ATPase by combining X-ray crystallography and electron cryomicroscopy. Molecular Cell, 25, 427–440.
8.
(a) HonmaY., IshiiY., Yamamoto-YamaguchiY., SassaT., AsahiK. (2003) Cotylenin A, a differentiation-inducing agent, and IFN-cooperatively induce apoptosis and have an antitumor effect on human non-small cell lung carcinoma cells in nude mice. Cancer Research, 63, 3659–3666; (b) Honma Y, Kasukabe T, Yamori T, Kato N, Sassa T. (2005) Antitumor effect of cotylenin A plus interferon-a: Possible therapeutic agents against ovary carcinoma. Gynecologic Oncology, 99, 680–688. (c) de Vries-van Leeuwen IJ, Kortekaas-Thijssen C, Nzigou Mandouckou JA, Kas S, Evidente A, de Boer AH (2010). Fusicoccin-A selectively induces apoptosis in tumor cells after interferon-α priming. Cancer Letters, 293, 198–206.
9.
(a) OttmannC., WeyandM., SassaT., InoueT., KatoN., WittinghoferA., OeckingC. (2009) A structural rationale for selective stabilization of antitumor interactions of 14–3–3 proteins by cotylenin A. Journal of Molecular Biology, 386, 913–919; (b) Takahashi M, Kawamura A, Jato N, Nishi T, Hamachi I, Ohkanda J. (2012). Phosphopeptide-dependent labeling of 14–3–3ζ proteins by fusicoccin based fluorescent probes. Angewandte Chemie International Edition, 51, 509–512; (c) Molzan M, Kasper S, Röglin L, Skwarczynska M, Sassa T, Inoue T, Breitenbuecher F, Ohkanda J, Kato N, Schuler M, Ottmann C. (2013) Stabilization of physical RAF/14–3–3 interaction by cotylenin A as treatment strategy for Ras mutant cancers. ACS Chemical Biology, 8, 1869–1875.
10.
(a) AsahiK., HonmaY., HazekiK., SassaT., KuboharaY., SakuraiA., TakahashiN. (1997) Cotylenin A, a plant-growth regulator, induces the differentiation in murine and human myeloid leukemia cells. Biochemical and Biophysical Research Communications, 238, 758–763; (b) Honma Y. (2002) Cotylenin A, a plant growth regulator, as a differentiation-inducing agent against myeloid leukemia. Leukemia and Lymphoma, 43, 1169–1178; (c) Matsunawa M, Ishii Y, Kasukabe T, Tomoyasu S, Ota H, Honma Y. (2006) Independence of cotylenin A-induced differentiation from transforming growth factor-b signaling system in human myeloid leukemia HL-60 cells. Leukemia and Lymphoma, 47, 733–740.
11.
FlackH.D., BernardinelliG. (2008) The use of X-ray crystallography to determine absolute configuration. Chrality, 20, 681–690.
12.
DegosL., WangZ.Y. (2001) All trans retinoic acid in acute promyelocytic leukemia. Oncogene, 20, 7140–7145.
13.
ReedL.J., MuenchH. (1938) A simple method of estimating fifty percent endpoints. The American Journal of Hygiene, 27, 493–497.
